These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 170344)

  • 1. The ontogeny of murine B lymphocytes. I. Induction of phenotypic conversion of Ia-to Ia+ lymphocytes.
    Hammerling U; Chin AF; Abbott J; Scheid MP
    J Immunol; 1975 Nov; 115(5):1425-31. PubMed ID: 170344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymus-repopulating capacity of cells that can be induced to differentiate to T cells in vitro.
    Komure K; Goldstein G; Boyse EA
    J Immunol; 1975 Jul; 115(1):195-8. PubMed ID: 50347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation of B lymphocytes in C3H/HeJ mice: the induction of Ia antigens by lipopolysaccharide.
    Watson J
    J Immunol; 1977 Mar; 118(3):1103-8. PubMed ID: 300386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ly-4.2: a cell membrane alloantigen of murine B lymphocytes. I. Population studies.
    McKenzie IF; Snell GD
    J Immunol; 1975 Feb; 114(2 pt 2):848-55. PubMed ID: 1078681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ia-restricted B-B cell interaction. I. The MHC haplotype of bone marrow cells present during B cell ontogeny dictates the self-recognition specificity of B cells in the polyclonal B cell activation by a B cell differentiation factor, B151-TRF2.
    Ono S; Takahama Y; Hamaoka T
    J Immunol; 1987 Nov; 139(10):3213-23. PubMed ID: 3316381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-dependent cellular cytotoxicity effector cells lack Ia antigens.
    Nelson DL; Sachs DH; Dickler HB
    J Immunol; 1977 Sep; 119(3):1034-40. PubMed ID: 330744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The synergistic effects of anti-IgM and monoclonal anti-Ia antibodies in induction of murine B lymphocyte activation.
    Baluyut AR; Subbarao B
    J Mol Cell Immunol; 1988; 4(1):45-57. PubMed ID: 3266924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of anti-plasma cell serum on B cells.
    Nariuchi H; Matuhasi T
    J Immunol; 1974 Feb; 112(2):462-7. PubMed ID: 4205202
    [No Abstract]   [Full Text] [Related]  

  • 9. Prostaglandin E2 and cAMP inhibit B lymphocyte activation and simultaneously promote IgE and IgG1 synthesis.
    Roper RL; Phipps RP
    J Immunol; 1992 Nov; 149(9):2984-91. PubMed ID: 1328389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse bone marrow lymphocytes and their differentiation.
    Ryser JE; Vassalli P
    J Immunol; 1974 Sep; 113(3):719-28. PubMed ID: 4213258
    [No Abstract]   [Full Text] [Related]  

  • 11. IgM antibody-dependent cell-mediated cytotoxicity in the Moloney sarcoma virus system: the involvement of T and B lymphocytes as effector cells.
    Lamon EW; Whitten HD; Skurzak HM; Andersson B; Lidin B
    J Immunol; 1975 Nov; 115(5):1288-94. PubMed ID: 1080777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ontogeny of murine B lymphocytes: sequence of B-cell differentiation from surface-immunoglobulin-negative precursors to plasma cells.
    Hämmerling U; Chin AF; Abbott J
    Proc Natl Acad Sci U S A; 1976 Jun; 73(6):2008-12. PubMed ID: 1084527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of BSF-1 during an in vivo, T-dependent immune response.
    Finkelman FD; Ohara J; Goroff DK; Smith J; Villacreses N; Mond JJ; Paul WE
    J Immunol; 1986 Nov; 137(9):2878-85. PubMed ID: 3489779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ia alloantigen(s) detected on thymocytes by use of a fluorescence-activated cell sorter.
    Fathman CG; Cone JL; Sharrow SO; Tyrer H; Sachs DH
    J Immunol; 1975 Aug; 115(2):584-9. PubMed ID: 1097521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression on mouse lymphoid cells of Th-B, an antigen common to mouse B cells and thymus cells.
    Yutoku M; Grossberg AL; Pressman D
    J Immunol; 1975 Jul; 115(1):69-74. PubMed ID: 1097506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ly-4.2: a cell membrane alloantigen of murine B lymphocytes. II. Functional studies.
    McKenzie IF
    J Immunol; 1975 Feb; 114(2 pt 2):856-62. PubMed ID: 1089720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse skin graft prolongation with donor strain bone marrow and anti-lymphocyte serum: surface markers of the active bone marrow cells.
    De Fazio S; Hartner WC; Monaco AP; Gozzo JJ
    J Immunol; 1985 Nov; 135(5):3034-8. PubMed ID: 2864375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of anti-Ia serum on mitogenic responses. I. Inhibition of the proliferative response to B cell mitogen, LPS, by specific anti-Ia sera.
    Niederhuber JE; Frelinger JA; Dugan E; Coutinho A; Shreffler DC
    J Immunol; 1975 Dec; 115(6):1672-6. PubMed ID: 1081105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyclonal B-cell activation by a B-cell differentiation factor B151-TRF2. IV. B151-TRF2-responsive F1 B cells consist of two separate populations capable of recognizing only one of the parental I-A products expressed on B cells.
    Takaháma Y; Ono S; Glimcher LH; Hamaoka T
    J Mol Cell Immunol; 1987; 3(3):177-94. PubMed ID: 3509923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo B lymphocyte-activating properties of monoclonal anti-delta antibodies. I. Determinants of B lymphocyte-activating properties.
    Goroff DK; Stall A; Mond JJ; Finkelman FD
    J Immunol; 1986 Apr; 136(7):2382-92. PubMed ID: 2419432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.